{"title":"Antidepressant effect of low dose nimodipine in the mouse behaviour despair model","authors":"P. Rataboli, A. Garg, K. Muchandi","doi":"10.5580/1e24","DOIUrl":null,"url":null,"abstract":"Dihydropyridine Calcium Channel Blockers (DHP-CCB) have been reported to exert conflicting effects in various experimental models of depression. We observed the effect of centrally acting DHP-CCB, nimodipine at various doses in behaviour despair model using Porsolt’s Forced Swim Test in mice. Nimodipine showed significant antidepressant activity only at 2.5 mg/kg given intraperitoneally. A possible therapeutic window phenomenon is thought to come to play at lower doses of the drug. Thus nimodipine can be developed as a strong weapon and added to the armamentarium used especially against cerebrovascular diseases where the possibility of depression setting in can not be ruled out.","PeriodicalId":22523,"journal":{"name":"The Internet Journal of Pharmacology","volume":"60 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2009-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/1e24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Dihydropyridine Calcium Channel Blockers (DHP-CCB) have been reported to exert conflicting effects in various experimental models of depression. We observed the effect of centrally acting DHP-CCB, nimodipine at various doses in behaviour despair model using Porsolt’s Forced Swim Test in mice. Nimodipine showed significant antidepressant activity only at 2.5 mg/kg given intraperitoneally. A possible therapeutic window phenomenon is thought to come to play at lower doses of the drug. Thus nimodipine can be developed as a strong weapon and added to the armamentarium used especially against cerebrovascular diseases where the possibility of depression setting in can not be ruled out.